Follow the people · Insider
Jonathan Slonin
Jonathan Slonin files insider transactions with the SEC as a chief medical officer of Pacira BioSciences (PCRX). We hold 2 disclosed purchases and sales filed since 5 August 2021, 1 of them in the last 90 days.
- Files forPCRX
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure18 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 August 2021 — 17 August 2026Chief Medical Officer · Pacira BioSciences (PCRX)37 Form 4 lines · source: SEC Form 4
Everything they disclosed
37 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 3,040 shares of Pacira BioSciencesSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- had shares withheld for tax on 4,728 shares of Pacira BioSciencesSEC Form 45 June 2026Common Stock · traded 3 June 2026 · filed 5 June 2026
- ▼ sold on the open market 3,261 shares of Pacira BioSciencesSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 3,261 shares of Pacira BioSciencesSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- was granted 54,546 shares of Pacira BioSciencesSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- was granted 54,546 shares of Pacira BioSciencesSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- had shares withheld for tax on 6,168 shares of Pacira BioSciencesSEC Form 43 February 2026Common Stock · traded 30 January 2026 · filed 3 February 2026
- had shares withheld for tax on 6,168 shares of Pacira BioSciencesSEC Form 43 February 2026Common Stock · traded 30 January 2026 · filed 3 February 2026
- had shares withheld for tax on 381 shares of Pacira BioSciencesSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- had shares withheld for tax on 381 shares of Pacira BioSciencesSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 3,960 shares of Pacira BioSciencesSEC Form 419 November 2025Common Stock · traded 17 November 2025 · filed 19 November 2025
- had shares withheld for tax on 315 shares of Pacira BioSciencesSEC Form 44 August 2025Common Stock · traded 1 August 2025 · filed 4 August 2025
- had shares withheld for tax on 5,084 shares of Pacira BioSciencesSEC Form 45 June 2025Common Stock · traded 3 June 2025 · filed 5 June 2025
- was granted 93,600 shares of Pacira BioSciencesSEC Form 44 February 2025Common Stock · traded 1 February 2025 · filed 4 February 2025
- had shares withheld for tax on 371 shares of Pacira BioSciencesSEC Form 46 January 2025Common Stock · traded 2 January 2025 · filed 6 January 2025
- ▼ sold on the open market 879 shares of Pacira BioSciencesSEC Form 46 January 2025Common Stock · traded 6 January 2025 · filed 6 January 2025
- had shares withheld for tax on 305 shares of Pacira BioSciencesSEC Form 42 August 2024Common Stock · traded 1 August 2024 · filed 2 August 2024
- ▼ sold on the open market 945 shares of Pacira BioSciencesSEC Form 42 August 2024Common Stock · traded 2 August 2024 · filed 2 August 2024
- was granted 437 shares of Pacira BioSciencesSEC Form 43 July 2024Common Stock · traded 28 June 2024 · filed 3 July 2024
- had shares withheld for tax on 914 shares of Pacira BioSciencesSEC Form 43 July 2024Common Stock · traded 1 July 2024 · filed 3 July 2024
- ▼ sold on the open market 2,836 shares of Pacira BioSciencesSEC Form 43 July 2024Common Stock · traded 2 July 2024 · filed 3 July 2024
- ▼ sold on the open market 5,012 shares of Pacira BioSciencesSEC Form 413 June 2024Common Stock · traded 11 June 2024 · filed 13 June 2024
- was granted 54,300 shares of Pacira BioSciencesSEC Form 413 June 2024Common Stock · traded 12 June 2024 · filed 13 June 2024
- had shares withheld for tax on 1,615 shares of Pacira BioSciencesSEC Form 45 June 2024Common Stock · traded 3 June 2024 · filed 5 June 2024
- was granted 10,000 shares of Pacira BioSciences (a derivative holding)SEC Form 44 January 2024Stock Option (Right to Buy) · traded 3 January 2024 · filed 4 January 2024
- was granted 5,000 shares of Pacira BioSciencesSEC Form 44 January 2024Common Stock · traded 2 January 2024 · filed 4 January 2024
- ▼ sold on the open market 471 shares of Pacira BioSciencesSEC Form 47 June 2023Common Stock · traded 6 June 2023 · filed 7 June 2023
- ▼ sold on the open market 490 shares of Pacira BioSciencesSEC Form 47 June 2023Common Stock · traded 7 June 2023 · filed 7 June 2023
- ▼ sold on the open market 308 shares of Pacira BioSciencesSEC Form 45 August 2022Common Stock · traded 3 August 2022 · filed 5 August 2022
- ▼ sold on the open market 924 shares of Pacira BioSciencesSEC Form 47 July 2022Common Stock · traded 5 July 2022 · filed 7 July 2022
- ▼ sold on the open market 24,800 shares of Pacira BioSciences (a derivative holding)SEC Form 48 June 2022Stock Option (Right to Buy) · traded 8 June 2022 · filed 8 June 2022
- ▼ sold on the open market 362 shares of Pacira BioSciencesSEC Form 48 June 2022Common Stock · traded 6 June 2022 · filed 8 June 2022
- was granted 9,900 shares of Pacira BioSciencesSEC Form 48 June 2022Common Stock · traded 8 June 2022 · filed 8 June 2022
- exercised options over 2,000 shares of Pacira BioSciences (a derivative holding)SEC Form 425 May 2022Stock Option (Right to Buy) · traded 23 May 2022 · filed 25 May 2022
- exercised options over 2,000 shares of Pacira BioSciencesSEC Form 425 May 2022Common Stock · traded 23 May 2022 · filed 25 May 2022
- was granted 10,000 shares of Pacira BioSciences (a derivative holding)SEC Form 45 August 2021Stock Option (Right to Buy) · traded 3 August 2021 · filed 5 August 2021
- was granted 5,000 shares of Pacira BioSciencesSEC Form 45 August 2021Common Stock · traded 3 August 2021 · filed 5 August 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.